Xconomy Forum: Tomorrow’s Biotech — Innovators and Innovations | Xconomy

Xconomy | National - Business + Technology in the Exponential Economy

Xconomy Forum: Tomorrow’s Biotech — Innovators and Innovations

April 30, 2009 – Agenda

1:30 – 2:00	Registration
2:00 – 2:20	Welcome James C. Mullen, President and CEO, Biogen Idec Bob Buderi, Founder and Editor in Chief, Xconomy
2:20 – 2:40	Case Study: Zafgen Thomas Hughes, President and CEO, Zafgen Maria Rupnick, Co-Founder, Zafgen, and Instructor of Medicine, Harvard Medical School
2:40 – 3:00	Case Study: Forma Therapeutics Steven Tregay, Founder, President, and CEO, Forma Therapeutics
3:00 – 4:00	Panel: New Frontiers for Public Biotechs Gilmore N. O’Neill, Senior Director, Experimental Neurology, Biogen Idec Sam Wadsworth, Group Vice President of Translational Research, Genzyme Eric Olson, VP of Program and Portfolio Management, Vertex Pharmaceuticals Michelle Dipp (moderator), Vice President and Head of the U.S. Centre of Excellence for External Drug Discovery, GlaxoSmithKline
4:00 – 4:25	Networking Break
4:25 – 4:45	Case Study: Ironwood Pharmaceuticals Peter Hecht, CEO, Ironwood Pharmaceuticals
4:45 – 5:05	Case Study: GlycoFi and Adimab Tillman Gerngross, Co-founder and scientific advisory board chair, GlycoFi, Co-founder and CEO, Adimab, and Professor of Engineering, Dartmouth
5:05 – 5:45	Fireside Chat Walter Gilbert, General Partner, BioVentures Investors, and University Professor Emeritus, Harvard George Church, Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School James Collins (moderator), University Professor and Professor of Biomedical Engineering, Boston University
5:45 – 7:00	Networking Reception

CLICK HERE FOR MORE DETAILS AND TO REGISTER.

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.